Collect. Czech. Chem. Commun. 2010, 75, 1229-1247
https://doi.org/10.1135/cccc2010077
Published online 2010-11-18 07:31:56

Rat liver microsomal metabolism of o-aminophenol and N-(2-methoxyphenyl)hydroxylamine, two metabolites of the environmental pollutant and carcinogen o-anisidine in humans

Karel Naimana, Petr Hodeka, Jiří Liberdaa, Heinz H. Schmeiserb, Eva Freic and Marie Stiborováa,*

a Department of Biochemistry, Faculty of Natural Sciences, Charles University in Prague, Albertov 2030, 128 43 Prague 2, Czech Republic
b Research Group Genetic Alteration in Carcinogenesis, National Center for Tumour Diseases, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
c Division of Preventive Oncology, National Center for Tumour Diseases, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany

References

1. International Agency for Research in Cancer (IARC): IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, No. 27. IARC, Lyon 1982.
2. Stabbert R., Schäfer K.-H., Biefel C., Rustemeier K.: Rapid Commun. Mass Spectrom. 2003, 17, 2125. <https://doi.org/10.1002/rcm.1161>
3. Kütting B., Göen T., Schwegler U., Fromme H., Uter W., Angerer J., Drexler H.: Int. J. Hyg. Environ. Health 2009, 212, 298. <https://doi.org/10.1016/j.ijheh.2008.07.004>
4. Richter E., Rosler S., Scherer G., Gostomzyk J. G., Grubl A., Kamer U., Behrendt H.: Int. Arch. Occup. Environ. Health 2001, 74, 421. <https://doi.org/10.1007/s004200100243>
5. Traupe H., Menge G., Kandt J., Karmaus W.: Dermatology 1997, 195, 112. <https://doi.org/10.1159/000245711>
6. Stiborová M., Schmeiser H. H., Breuer A., Frei E.: Gen. Physiol. Biophys. 2001, 20, 267.
7. Stiborová M., Mikšanová M., Havlíček V., Schmeiser H. H., Frei E.: Mutat. Res. 2002, 500, 49. <https://doi.org/10.1016/S0027-5107(01)00295-0>
8. Stiborová M., Mikšanová M., Šulc M., Rýdlová H., Schmeiser H. H., Frei E.: Int. J. Cancer 2005, 116, 667. <https://doi.org/10.1002/ijc.21122>
9. Rýdlová H., Mikšanová M., Ryšlavá H., Stiborová M.: Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 2005, 49, 441. <https://doi.org/10.5507/bp.2005.077>
10. Naiman K., Dračínská H., Martínková M., Šulc M., Dračínský M., Kejíková L., Hodek P., Hudeček J., Liberda J., Schmeiser H. H., Frei E., Stiborová M.: Chem. Res. Toxicol. 2008, 21, 1610. <https://doi.org/10.1021/tx8001127>
11. Stiborová M., Mikšanová M., Smrček S., Bieler C. A., Breuer A., Schmeiser H. H., Frei E.: Carcinogenesis 2004, 25, 833. <https://doi.org/10.1093/carcin/bgh061>
12. Mikšanová M., Novák P., Frei E., Stiborová M.: Collect. Czech. Chem. Commun. 2004, 69, 589. <https://doi.org/10.1135/cccc20040589>
13. Akazawa M., Takasaki M., Tomoda A.: Tohoku J. Exp. Med. 2000, 192, 301. <https://doi.org/10.1620/tjem.192.301>
14. Puiu M., Răducan A., Babaligea I., Oancea D.: Bioprocess Biosyst. Eng. 2008, 31, 579. <https://doi.org/10.1007/s00449-008-0206-8>
15. Balaban A. T., Garfield R. E., Lesko M. J., Seitz W. A.: Org. Prep. Proced. Int. 1998, 30, 439. <https://doi.org/10.1080/00304949809355306>
16. Dračínská H., Mikšanová M., Svobodová M., Smrček S., Frei E., Schmeiser H. H., Stiborová M.: Neuroendocrinol. Lett. 2006, 27 (Suppl. 2), 9.
17. Stiborová M., Martínek V., Rýdlová H., Hodek P., Frei E.: Cancer Res. 2002, 62, 5678.
18. Arlt V. M., Stiborová M., Henderson C. J., Thiemann M., Frei E., Aimová D., Singhs R., da Costa G. G., Schmitz O. J., Farmer P. B., Wolf C. R., Phillips D. H.: Carcinogenesis 2008, 29, 656. <https://doi.org/10.1093/carcin/bgn002>
19. Frei E., Bieler C. A., Arlt V. M., Wiessler M., Stiborová M.: Biochem. Pharmacol. 2002, 64, 289. <https://doi.org/10.1016/S0006-2952(02)01072-9>
20. Gupta R. C., Reddy M. V., Randerath K: Carcinogenesis 1982, 3, 1081. <https://doi.org/10.1093/carcin/3.9.1081>
21. Randerath E., Agrawal H. P., Weaver J. A., Bordelon C. B., Randerath K.: Carcinogenesis 1985, 6, 1117. <https://doi.org/10.1093/carcin/6.8.1117>
22. Reddy M. V., Bleicher W. T., Blackburn G. R., Mackerer E. R.: Carcinogenesis 1990, 11, 1349. <https://doi.org/10.1093/carcin/11.8.1349>
23. Kim D., Kadlubar F. F., Teitel C. H., Guengerich F. P.: Chem. Res. Toxicol. 2004, 17, 529. <https://doi.org/10.1021/tx034267y>
24. Kohno K., Miyake M., Sano O., Tanaka-Kataoka M., Yamamoto S., Koya-Miyata S., Arai N., Fujii M., Watanabe H., Ushio S., Iwaki K., Fukuda S.: Biol. Pharm. Bull. 2008, 31, 1938. <https://doi.org/10.1248/bpb.31.1938>
25. Uruma T., Yamaguchi H., Fukuda M., Kawakami H., Goto H., Kishimoto T., Yamamoto Y., Tomoda A., Kamiya S.: J. Med. Microbiol. 2005, 54, 1143. <https://doi.org/10.1099/jmm.0.46090-0>
26. Zheng C. L., Che X. F., Akiyama S., Miyazawa K., Tomoda A.: Int. J. Oncol. 2010, 36, 641.
27. Kirchner G., Bayer U.: Hum. Toxicol. 1992, 1, 387. <https://doi.org/10.1177/096032718200100404>
28. Brennan R. J., Schiestl R. H.: Mutagenesis 1997, 12, 215. <https://doi.org/10.1093/mutage/12.4.215>
29. Okhuma Y., Kawanishi S.: Arch. Biochem. Biophys. 2001, 389, 49.
30. Cheng G., Shi Y., Sturla S., Jalas J., McIntee E. J., Villalta P. W., Wang M., Hecht S. S.: Chem. Res. Toxicol. 2003, 16, 145. <https://doi.org/10.1021/tx025614r>
31. International Agency for Research in Cancer (IARC): IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, Vol. 88, pp. 39–325. IARC, Lyon 2006.
32. U.S. Department of Health and Human Services: 11th Report on Carcinogens. U.S. Government Printing Office, Washington, DC 2004.
33. Dhareshwar S. S., Stella V. J.: J. Pharm. Sci. 2008, 97, 4184. <https://doi.org/10.1002/jps.21319>
34. Imaoka S., Osada M., Minamiyama Y., Yukimura T., Toyokuni S., Takemura S., Hiroi T., Funae Y.: Cancer Lett. 2004, 203, 117. <https://doi.org/10.1016/j.canlet.2003.09.009>